InsidersTradesSigma
Total declarations
Company
▲ Purchases (1 ops.)
▼ Sales (0 ops.)
Discover the detailed record of transactions filed by Bernard Gilly, Chief Executive Officer. Officer active across 1 companies, notably Gensight Biologics S.A.. In total, 1 reports have been logged. Total volume traded: €117k. The latest transaction was filed on 7 April 2022 (Acquisition). Regulator: AMF. All data is accessible without signup.
Declarations1 total
€117,12550,000 shares@ €2.34250.51% mcap100.0% of flow
ActionEuronext Paris
2022DD835024·
Ideal exit: 2 Jan 2023 (T+270)
1 of 1 declaration
About Bernard Gilly
Bernard Gilly is the Chief Executive Officer of GenSight Biologics S.A. He is responsible for the strategic and operational direction of the company, which focuses on developing treatments for eye diseases. His experience in the biopharmaceutical sector is an asset for GenSight.
